{"id":793075,"date":"2024-12-06T08:33:29","date_gmt":"2024-12-06T13:33:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/"},"modified":"2024-12-06T08:33:29","modified_gmt":"2024-12-06T13:33:29","slug":"alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/","title":{"rendered":"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium"},"content":{"rendered":"
\n

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the \u201cCompany\u201d) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT\u00ae<\/sup>, today announced that CFO Raphi Levy<\/strong>will present at the <\/strong>Ladenburg Oncology Innovators & Investors Symposium.<\/p>\n\n\n\n\n\n\n\n
Event:<\/td>\nLadenburg Oncology Innovators & Investors Symposium<\/td>\n<\/tr>\n
Format:<\/td>\nPresentation and 1-on-1 Meetings<\/td>\n<\/tr>\n
Date:<\/td>\nDecember 12, 2024<\/td>\n<\/tr>\n
Time:<\/td>\n11:00AM \u2013 11:25AM EST<\/td>\n<\/tr>\n
Location:<\/td>\nVirtual<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

\u00a0<\/p>\n

Please reach out to your Ladenburg representative to schedule 1-on-1 meetings with Mr. Levy.<\/p>\n

\n About Alpha Tau Medical Ltd.<\/strong>\n <\/p>\n

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.<\/p>\n

\n About Alpha DaRT<\/strong>
\n \u00ae<\/sup>\n <\/p>\n

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it.<\/p>\n

Investor Relations Contact: IR@alphatau.com<\/a><\/u><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the \u201cCompany\u201d) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT\u00ae, today announced that CFO Raphi Levywill present at the Ladenburg Oncology Innovators & Investors Symposium. Event: Ladenburg Oncology Innovators & Investors Symposium Format: Presentation and 1-on-1 Meetings Date: December 12, 2024 Time: 11:00AM \u2013 11:25AM EST Location: Virtual \u00a0 \u00a0 \u00a0 Please reach out to your Ladenburg representative to schedule 1-on-1 meetings with Mr. Levy. About Alpha Tau Medical Ltd. Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology … <\/p>\n

Continue reading “Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-793075","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAlpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the \u201cCompany\u201d) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT\u00ae, today announced that CFO Raphi Levywill present at the Ladenburg Oncology Innovators & Investors Symposium. Event: Ladenburg Oncology Innovators & Investors Symposium Format: Presentation and 1-on-1 Meetings Date: December 12, 2024 Time: 11:00AM \u2013 11:25AM EST Location: Virtual \u00a0 \u00a0 \u00a0 Please reach out to your Ladenburg representative to schedule 1-on-1 meetings with Mr. Levy. About Alpha Tau Medical Ltd. Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology … Continue reading "Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-06T13:33:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA3NiM2NjEzNTgzIzIyNDk1Mzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium\",\"datePublished\":\"2024-12-06T13:33:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/\"},\"wordCount\":224,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjA3NiM2NjEzNTgzIzIyNDk1Mzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/\",\"name\":\"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjA3NiM2NjEzNTgzIzIyNDk1Mzg=\",\"datePublished\":\"2024-12-06T13:33:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjA3NiM2NjEzNTgzIzIyNDk1Mzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjA3NiM2NjEzNTgzIzIyNDk1Mzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/","og_locale":"en_US","og_type":"article","og_title":"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium - Market Newsdesk","og_description":"JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the \u201cCompany\u201d) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT\u00ae, today announced that CFO Raphi Levywill present at the Ladenburg Oncology Innovators & Investors Symposium. Event: Ladenburg Oncology Innovators & Investors Symposium Format: Presentation and 1-on-1 Meetings Date: December 12, 2024 Time: 11:00AM \u2013 11:25AM EST Location: Virtual \u00a0 \u00a0 \u00a0 Please reach out to your Ladenburg representative to schedule 1-on-1 meetings with Mr. Levy. About Alpha Tau Medical Ltd. Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology … Continue reading \"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-06T13:33:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA3NiM2NjEzNTgzIzIyNDk1Mzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium","datePublished":"2024-12-06T13:33:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/"},"wordCount":224,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA3NiM2NjEzNTgzIzIyNDk1Mzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/","name":"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA3NiM2NjEzNTgzIzIyNDk1Mzg=","datePublished":"2024-12-06T13:33:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA3NiM2NjEzNTgzIzIyNDk1Mzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjA3NiM2NjEzNTgzIzIyNDk1Mzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpha-tau-to-participate-in-ladenburgs-oncology-innovators-investors-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alpha Tau to Participate in Ladenburg\u2019s Oncology Innovators & Investors Symposium"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/793075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=793075"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/793075\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=793075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=793075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=793075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}